ArticlePloS one2025
Suicide rates in Germany in lockdown and non-lockdown phases during the COVID-19 pandemic in 2020/2021.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Association between temperature, duration of sunshine and suicidal mortality in Germany (2015-2023)].Der Nervenarzt · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrary to the cautions of many, suicide rates during the first COVID-19 pandemic lockdown in Germany did not rise, but declined. With the accessibility of the 2021 weekly suicide data, it was possible to analyze suicide rates and the proportion of suicide methods during the lockdown and non-lockdown phases and during the first 21 months of the pandemic compared to the previous ten years. An interrupted time-series analysis based on a linear regression was used. For the comparisons of predicted and observed suicide rates, excess suicide mortality rates (ESMR) were chosen among others. Changes in the choice of method were analyzed by comparing the rates of different methods in lockdown- and non-lockdown phases. Since the start of the COVID-19 pandemic, suicide mortality in 2020/2021 was significantly higher than expected (ESMR = 1.0161; 95% CI: 1.0005; 1.0317). Registered suicide mortality was lower than expected during the lockdown phases in these years (ESMR = 0.9477; 95% CI: 0.9128; 0.9825) and higher during non-lockdown phases (ESMR = 1.0353; 95% CI: 1.0178; 1.0528). A MANOVA revealed a significant difference of the absolute number of suicides between lockdown and non-lockdown periods (factor "lockdown": F(1,100) = 9.47; p = 0.003). A shift of suicide methods in the comparison of these periods could not be detected. Our results are in line with the rise in yearly absolute numbers of suicides in 2022 in Germany and illustrate that even though suicide rates declined during lockdowns, there was a general rise since the beginning of the COVID-19 pandemic, especially during the non-lockdown periods. This hints towards a "postponement effect", probably as loosening of the lockdown restrictions makes suicide methods more easily accessible and more suicides than expected are present in the following non-lockdown periods. More research is needed to better understand the mechanisms influencing suicidality during lockdowns and the COVID-19 pandemic in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.